Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing amoxicillin-esomeprazole high-dose dual therapy to levofloxacin triple therapy for Helicobacter pylori eradication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amoxicillin-esomeprazole HDDT (amoxicillin-esomeprazole high-dose dual therapy)
  • levofloxacin triple therapy

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Helicobacter Pylori Infection, Helicobacter Pylori Eradication | Phase 4 | Status: UNKNOWN